Galectin-3 and Pentraxin-3 as Potential Biomarkers in Chronic Coronary Syndrome and Atrial Fibrillation: Insights from a 131-Patient Cohort.

However, the absence of a significant trend in our cohort might be attributed to sample distribution or the underlying predominance of ischemic pathology over arrhythmogenic remodeling [ 6 ].

also in 9,775 other papers

With a total of 131 patients divided into two nearly equal groups (N-CCS and S-CCS), the statistical power to detect subtle but clinically meaningful differences may have been limited, particularly for parameters that approached significance.

also in 8,237 other papers